[ad_1] The worldwide impact of the COVID-19 pandemic has led to an unprecedented effort to develop vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in a timeframe never imagined before. . Although some vaccines have started to be administered on a large scale, scientists and governments are facing …
Read More »Particulate matter levels can play a significant role in the transmission of SARS-CoV-2
[ad_1] Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome agent coronavirus 2 (SARS-CoV-2), has infected more than 63.93 million people and caused the deaths of over 1.49 millions around the world. The virus is mainly spread through respiratory or aerosol droplets that remain suspended in the air …
Read More »Deletion mutations of SARS-CoV-2 may have attenuated infectivity in some strains
[ad_1] Caused by the severe acute respiratory syndrome agent coronavirus 2 (SARS-CoV-2), the 2019 coronavirus disease (COVID-19) pandemic has reached over 191 countries and infected more than 63.98 million people. Scientists around the world are racing to better understand the virus, how it is transmitted and how it affects the …
Read More »PTC299 inhibits SARS-CoV-2 replication and suppresses inflammatory cytokine production
[ad_1] The 2019 coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a serious global public health crisis. To date, the virus has infected 63.75 million people and has caused the deaths of over 1.47 million worldwide, showing that there is an urgent …
Read More »Fibromyalgia during COVID-19, anxiety and pain
[ad_1] Early research on the impact of the COVID-19 pandemic has found persistent related anxiety in the general population. Researchers in the UK speculated that this anxiety would be associated with increased pain in chronic pain patients diagnosed with fibromyalgia (FM). Fibromyalgia affects approximately 2% of the world population. A …
Read More »Marinomed designs clinical trial with Carragelose nasal spray as a prophylaxis for COVID-19
[ad_1] Marinomed Biotech AG, a globally operating biopharmaceutical company, is pleased to announce today that Swansea University Medical School is planning a clinical trial with Iota / kappa-carrageenan nasal spray as a COVID-19 prophylaxis for healthcare professionals (ICE-COVID) . The investigator-initiated study in Swansea will recruit 480 healthcare professionals who …
Read More »Researchers reveal how SARS-CoV-2 reaches the brain
[ad_1] Using post mortem tissue samples, a team of researchers from Charité – Universitätsmedizin Berlin has studied the mechanisms by which the novel coronavirus can reach the brains of COVID-19 patients and how the immune system responds to the virus once it does. The results, which show that SARS-CoV-2 enters …
Read More »Highly functional immune response in asymptomatic SARS-CoV-2 infection
[ad_1] Singapore researchers conducted a study showing that asymptomatic individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – trigger a response efficient, balanced and coordinated cellular immune system that protects the host without giving the impression of triggering pathological …
Read More »Research suggests the importance of vitamin D for good health in the context of COVID-19
[ad_1] As the coronavirus disease (COVID-19) pandemic continues to spread globally, proactive measures to reduce the risk of infection are vital as there is still no approved vaccine to block severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2) nor drugs approved for the safe treatment of COVID-19 disease. Vitamin D …
Read More »Virusend TX-10 Cleaner rapidly reduces SARS-CoV-2 infectivity
[ad_1] Researchers from the Liverpool School of Tropical Medicine conducted a study showing that a new disinfectant called Virusend TX-10 is highly effective in inactivating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent responsible for it. current coronavirus disease 2019 (covid19. The study showed that Virusend TX-10 reduced SARS-CoV-2 …
Read More »